Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anna Lojko"'
Autor:
Natalia Popierz-Rydlewska, Sylwia Merkiel-Pawłowska, Anna Łojko-Dankowska, Mieczysław Komarnicki, Wojciech Chalcarz
Publikováno v:
PLoS ONE, Vol 18, Iss 12, p e0295308 (2023)
IntroductionIn the literature there is lack of information on the influence of gender and time since autologous hematopoietic stem cell transplantation (HSCT) on the immune reconstitution in multiple myeloma (MM) patients.ObjectiveThe aim of this stu
Externí odkaz:
https://doaj.org/article/a9ee3956a7474729a4db5fb3816ebc6a
Autor:
Andrzej Jakubowiak, Tomasz Wrobel, Krzysztof Jamroziak, Tadeusz Kubicki, Pawel Robak, Jarosław Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Adam Nowicki, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Pula, Justyna Rybka, Lidia Usnarska-Zubkiewicz, Olga Czabak, Andrew Stefka, Benjamin Derman, Dominik Dytfeld
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S6
Autor:
Elżbieta Graczyk-Pol, Anna Lojko-Dankowska, Jolanta Gozdzik, Anna Koclęga, Agnieszka Tomaszewska, Beata Wójcik, Joanna Dziopa, M. Barańska, Mieczysław Komarnicki, Jacek Nowak, Marta Zubala, Sebastian Giebel, Jacek Wachowiak, Slawomira Kyrcz-Krzemien, Kazimierz Hałaburda, Jerzy Kowalczyk, Andrzej Hellmann, Tomasz Czerw, Agnieszka Witkowska, Krzysztof Kałwak, Maria Bieniaszewska, Lidia Gil, Anna Pieczonka, Andrzej Szczepiński, Urszula Szlendak, Slawomir Gwozdowicz, Sylwia Madej, Marta Rogatko-Koros, Jan Styczyński, Renata Mika-Witkowska, Anna Czyż, Barbara Nasiłowska-Adamska, Agnieszka Gawron, Miroslaw Markiewicz, Monika Mielcarek, Krzysztof Warzocha, Kazimierz Kuliczkowski, Mariusz Wysocki, Jarosław Dybko, Agnieszka Kucharska, Daria Pawliczak, Emilia Jaskula, Jerzy Holowiecki, Andrzej Lange, Katarzyna Koscinska, Klaudia Nestorowicz, Anna Gronkowska, Wiesław Wiktor Jędrzejczak, Katarzyna Drabko
Publikováno v:
Human Immunology. 79:403-412
Serious risks in unrelated hematopoietic stem cell transplantation (HSCT) including graft versus host disease (GvHD) and mortality are associated with HLA disparity between donor and recipient. The increased risks might be dependent on disparity in n
Autor:
Anna Przybylowicz-Chalecka, Malgorzata Jarmuz-Szymczak, Lidia Gil, Zuzanna Kanduła, Anna Lojko-Dankowska, Monika Adamska, Ewelina Kowal-Wisniewska, Monika Joks, Marta Barańska
Publikováno v:
Blood. 138:1222-1222
Background: Therapy-related acute myeloid leukemia (t-AML) represents emerging challenge of the modern oncology as a life-threatening complication of cytotoxic therapy. Disease characterises poor prognosis and presence of adverse cytogenetic and gene
Autor:
Lidia Gil, Wojciech Jurczak, Anna Lojko-Dankowska, Jan Walewski, Wanda Knopinska-Posluszny, Barbara Nasiłowska-Adamska, Jan Maciej Zaucha, Manko Joanna, Anna Czyż, Tomasz Wróbel, Joanna Drozd-Sokołowska, Tomasz Czerw, Edyta Subocz, Agnieszka Kolkowska, Szymanska Agata, Dorota Hawrylecka, Mieczysław Komarnicki, Monika Długosz-Danecka, Marek Hus, Joanna Romejko-Jarosinska, Justyna Rybka, Agnieszka Giza, Ewa Paszkiewicz, Sebastian Giebel
Publikováno v:
Blood. 134:5276-5276
Background Brentuximab vedotin (BV) is an effective salvage treatment in patients with relapsing/progressive Hodgkin lymphoma (HL). However, it is unclear how much BV improved the outcome of BV naïve patients who relapsed after autologous hematopoie
Autor:
Grzegorz Helbig, Beata Piatkowska-Jakubas, Anna Lojko-Dankowska, Jan Walewski, Mieczysław Komarnicki, Joanna Romejko-Jarosinska, Anna Kopińska, Dominik Dytfeld, Wanda Knopinska-Posluszny, Barbara Nasiłowska-Adamska, Piotr Boguradzki, Andrzej Hellmann, Lidia Poplawska, Slawomira Kyrcz-Krzemien, Anna Czyż, Dorota Hawrylecka
Publikováno v:
Annals of Hematology
This report is a retrospective analysis of 65 patients with peripheral T cell lymphoma (PTCL), who underwent high-dose therapy and autologous hematopoietic stem cell transplantation (autoHCT) as a consolidation of first response achieved with either
Autor:
Tomasz Wróbel, Elzbieta Kalicinska, Jan Maciej Zaucha, Marta Morawska, Krzysztof Giannopoulos, Krzysztof Jamroziak, Ewa Lech-Marańda, Michał Taszner, Agnieszka Szeremet, Bartosz Małcecki, Anna Łojko-Dankowska, Dominik Dytfeld
Publikováno v:
HemaSphere, Vol 7, p e4339598 (2023)
Externí odkaz:
https://doaj.org/article/b2bd3f8abfd54849b0a5d9884b2a1208
Autor:
Joanna Romejko-Jarosinska, Anna Czyż, Andrzej Hellmann, Dominik Dytfeld, Mieczysław Komarnicki, Lidia Gil, Anna Lojko-Dankowska, Adam Nowicki, Wanda Knopinska-Posluszny, Jan Walewski
Publikováno v:
Leukemia & Lymphoma. 54:973-978
This report is an analysis of patients with Hodgkin lymphoma who relapsed after autologous stem cell transplant (autoHCT) and who were treated with gemcitabine-based therapy as a bridge to either allogeneic or second autologous transplant. Sixteen pa
Autor:
Maria Sadus-Wojciechowska, Jerzy Holowiecki, Magdalena Matuszak, Sebastian Giebel, Anna Czyż, Tomasz Czerw, Patrycja Mensah-Glanowska, Jacek Najda, Agnieszka Piekarska, Barbara Nasiłowska-Adamska, Wlodzimierz Mendrek, Malgorzata Maria Sobczyk Kruszelnicka, Anna Lojko-Dankowska
Publikováno v:
Blood. 132:3391-3391
Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a standard of care for patients with high risk acute myeloid leukemia (AML). However, the procedure using conventional myeloablative conditioning regimens based on either bu
Autor:
Anna Czyż, Wanda Knopinska-Posluszny, Mieczysław Komarnicki, Wojciech Jurczak, Monika Joks, Magdalena Witkowska, Monika Długosz-Danecka, Justyna Rybka, Piotr Smolewski, Jan Maciej Zaucha, Dorota Hawrylecka, Ewa Paszkiewicz, Anna Lojko-Dankowska, Joanna Drozd-Sokołowska, Edyta Subocz, Ewa Lech Maranda, Sebastian Giebel, Tomasz Wróbel, Jan Walewski, Agnieszka Kolkowska, Szymanska Agata
Publikováno v:
Blood. 132:5375-5375
An optimal treatment for patients with primary refractory or relapsed (R/R) Hodgkin lymphoma (HL) who did not respond to standard salvage therapy has not been established. Brentuximab vedotin (BV) and bendamustine (B) used as monotherapy were shown t